Deinove’s proposed capital raising (€9.3m) should allow the company to continue to develop its technology to the point when commercial revenues are expected to begin (2017/18). The intended distribution of the proceeds among Deinove’s businesses highlights the increased importance of the Deinochem offering within Deinove’s portfolio. It also highlights the greater number of potential revenue-generating projects beyond biofuels to which Deinove can now point.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Funding the road to commercial deployment
- Published:
08 Dec 2015 - Author:
-
Pages:
2
Deinove’s proposed capital raising (€9.3m) should allow the company to continue to develop its technology to the point when commercial revenues are expected to begin (2017/18). The intended distribution of the proceeds among Deinove’s businesses highlights the increased importance of the Deinochem offering within Deinove’s portfolio. It also highlights the greater number of potential revenue-generating projects beyond biofuels to which Deinove can now point.